Offspring Biosciences Proudly Supports Development of First-in-Class PET Ligand for Non-AD Tauopathies
News & Press Releases
- Feb 19
- 2 min
Closed! Senior Research Scientist in Histopathology
- Feb 9
- 2 min
How Life Science Companies Can Receive Support In Their Work
- Feb 2
- 1 min
Åsa Johansson. New Head of Operations
- Jan 24
- 2 min
Flagship Biosciences and Offspring Biosciences Partner to Provide Complete Global Assay Development Services from Target Identification to Companion Diagnostics
- Jan 22
- 1 min
Anders Nordström. New Chairman of the Board
- Oct 6, 2021
- 1 min
Closed: Join the Offspring Biosciences Team
- Sep 16, 2021
- 1 min
Offspring Biosciences in research collaboration with BioArctic
- Sep 16, 2021
- 1 min
Offspring Biosciences in research collaboration developing alpha-synuclein PET ligand
- Sep 16, 2021
- 1 min
Developing a new drug is a long and costly process with many pitfalls
- Sep 16, 2021
- 1 min
Our new innovative tissue staining platform turns complexity into simplicity
- Sep 16, 2021
- 2 min
Offspring assist AstraZeneca with diabetes project aimed to validate a potential novel biomarker
- Sep 16, 2021
- 1 min
Offspring supports MedImmune in a study published in Diabetes
About Us
Quick links
News
Established in 2012, Offspring Biosciences is a cell and tissue focused, research and development contract research organisation, that promotes scientific excellence in support of the biotechnology and pharmaceutical industry.
Forskargatan 20J
SÖDERTÄLJE, SWEDEN
Socials
Offspring Biosciences AB © 2024 All Rights Reserved